| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF347-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-27350 | |||
| BSA Free | NB100-56747SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide Free | NBP2-27415 | |||
| BSA Free | NB100-56528SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-25092-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 347-DR-100/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-80065 | |||
![Western Blot: TRAIL R1/TNFRSF10A Antibody (32A1380) [NB100-56747] - Analysis of DR4 in Daudi cell lysate using DR4 antibody at 2 ug/ml. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/TRAIL-R1-TNFRSF10A-Antibody-32A1380-Western-Blot-NB100-56747-img0002.jpg "Western Blot: TRAIL R1/TNFRSF10A Antibody (32A1380) [NB100-56747] - Analysis of DR4 in Daudi cell lysate using DR4 antibody at 2 ug/ml. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![Simple Western: TRAIL R1/TNFRSF10A Antibody (32A1380) [NB100-56747] - Simple Western lane view shows a specific band for TRAIL R1 in 0.5 mg/ml of Daudi lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system. * Non-specific interaction with the 230 kDa Simple Western standard may be seen with this antibody](http://images.novusbio.com/fullsize/TRAIL-R1-TNFRSF10A-Antibody-32A1380-Simple-Western-NB100-56747-img0003.jpg)
![Western Blot: TRAIL R1/TNFRSF10A Antibody (32A242) [NB100-56528] - Analysis using Azide/BSA FREE version of NB100-56528. Analysis of 20 ug of total cell lysate from HeLa cells with DR4 antibody at 2 ug/ml. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/TRAIL-R1-TNFRSF10A-Antibody-32A242-Western-Blot-NB100-56528-img0003.jpg "Western Blot: TRAIL R1/TNFRSF10A Antibody (32A242) [NB100-56528] - Analysis using Azide/BSA FREE version of NB100-56528. Analysis of 20 ug of total cell lysate from HeLa cells with DR4 antibody at 2 ug/ml. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![Western Blot: TRAIL R1/TNFRSF10A Antibody (32A242) [NB100-56528] - Analysis of 20 ug of total cell lysate from HeLa cells with DR4 antibody at 2 ug/ml. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/TRAIL-R1-TNFRSF10A-Antibody-32A242-Western-Blot-NB100-56528-img0002.jpg)
![Western Blot: TRAILR1/TNFRSF10A Antibody [NBP2-25092] - Western Blot Validation in Cell Lines. Loading: 15 ug of cell lysates per lane. Antibodies: DR4 NBP2-25092 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Western-Blot-NBP2-25092-img0011.jpg "Western Blot: TRAILR1/TNFRSF10A Antibody [NBP2-25092] - Western Blot Validation in Cell Lines. Loading: 15 ug of cell lysates per lane. Antibodies: DR4 NBP2-25092 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.")
![Immunocytochemistry/Immunofluorescence: TRAILR1/TNFRSF10A Antibody [NBP2-25092] - Staining of Jurkat cells with DR4 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-25092-img0003.jpg)
![Immunohistochemistry: TRAILR1/TNFRSF10A Antibody [NBP2-25092] - Immunofluorescence Validation of DR4. Immunofluorescent analysis of 4% paraformaldehyde-fixed human spleen tissue labeling DR4 with NBP2-25092 at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody (red) and DAPI staining (blue). Image showing membrane staining on human spleen cells.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Immunohistochemistry-NBP2-25092-img0009.jpg)
![<b>Independent Antibodies Validation. </b>Western Blot: TRAILR1/TNFRSF10A Antibody [NBP2-25092] - Independent Antibody Validation (IAV) via Protein Expression Profile in Cell LinesLoading: 15 ug of lysates per lane.Antibodies: DR4 NBP2-25092 (1 ug/mL), DR4 NBP1-76473 ( 4 ug/mL), and beta-actin (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Western-Blot-NBP2-25092-img0008.jpg)
![<b>Genetic Strategies Validation. </b>Western Blot: TRAILR1/TNFRSF10A Antibody [NBP2-25092] - KO Validation in HeLa Cells. Loading: 10 ug of HeLa WT cell lysates or TRAILR1/TNFRSF10A KO cell lysates. Antibodies: TRAILR1/TNFRSF10A [NBP2-25092] (1 ug/ml) and beta-actin [NBP1-76692] (1 ug/ml), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Western-Blot-NBP2-25092-img0010.jpg)
![Immunohistochemistry: TRAILR1/TNFRSF10A Antibody [NBP2-25092] - Staining of human spleen tissue with antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Immunohistochemistry-NBP2-25092-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: TRAILR1/TNFRSF10A Antibody [NBP2-33716] - Immunofluorescent staining of human cell line A549 shows localization to nucleus.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-33716-img0002.jpg "Immunocytochemistry/Immunofluorescence: TRAILR1/TNFRSF10A Antibody [NBP2-33716] - Immunofluorescent staining of human cell line A549 shows localization to nucleus.")
![Immunohistochemistry-Paraffin: TRAILR1/TNFRSF10A Antibody [NBP2-33716] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Immunohistochemistry-Paraffin-NBP2-33716-img0006.jpg)
![Immunohistochemistry-Paraffin: TRAILR1/TNFRSF10A Antibody [NBP2-33716] - Staining of human small intestine shows moderate cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Immunohistochemistry-Paraffin-NBP2-33716-img0003.jpg)
![Immunohistochemistry-Paraffin: TRAILR1/TNFRSF10A Antibody [NBP2-33716] - Staining of human small intestine shows strong cytoplasmic positivity in lymphoid cells.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Immunohistochemistry-Paraffin-NBP2-33716-img0004.jpg)
![Immunohistochemistry-Paraffin: TRAILR1/TNFRSF10A Antibody [NBP2-33716] - Staining of human cerebral cortex shows no positivity in neurons as expected.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Immunohistochemistry-Paraffin-NBP2-33716-img0005.jpg)
![Immunohistochemistry-Paraffin: TRAILR1/TNFRSF10A Antibody [NBP2-33716] - Staining of human pancreas shows no positivity in exocrine glandular cells as expected.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-Immunohistochemistry-Paraffin-NBP2-33716-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: TRAIL R1/TNFRSF10A Antibody (DR-4-02) - Azide Free [NBP2-31343] - Staining (confocal microscopy) of HeLa human cervix carcinoma cell line transfected with TRAIL-R1 expression plasmid using anti-human TRAIL-R1 (DR-4-02).](http://images.novusbio.com/fullsize/TRAIL-R1-TNFRSF10A-Antibody-DR-4-02-Azide-Free-Immunofluorescence-NBP2-31343-img0001.jpg "Immunocytochemistry/Immunofluorescence: TRAIL R1/TNFRSF10A Antibody (DR-4-02) - Azide Free [NBP2-31343] - Staining (confocal microscopy) of HeLa human cervix carcinoma cell line transfected with TRAIL-R1 expression plasmid using anti-human TRAIL-R1 (DR-4-02).")
![Flow Cytometry: TRAIL R1/TNFRSF10A Antibody (DR-4-02) - Azide Free [NBP2-31343] - Using the PE direct conjugate Surface staining of CD261-transfected HEK-293 cells with anti-CD261/TRAIL-R1 (DR-4-02) PE.](http://images.novusbio.com/fullsize/TRAIL-R1-TNFRSF10A-Antibody-DR-4-02-Azide-Free-Flow-Cytometry-NBP2-31343-img0002.jpg)
![Immunohistochemistry-Paraffin: TRAILR1/TNFRSF10A Antibody (TR1.02) [NBP2-80069] - Negative control.](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-TR1-02-Immunohistochemistry-Paraffin-NBP2-80069-img0002.jpg "Immunohistochemistry-Paraffin: TRAILR1/TNFRSF10A Antibody (TR1.02) [NBP2-80069] - Negative control.")
![Immunohistochemistry-Paraffin: TRAILR1/TNFRSF10A Antibody (TR1.02) [NBP2-80069] - Immunohistochemistry detection of endogenous TRAIL-R1 in paraffin-embedded human carcinoma tissues (colon, tonsil) using mAb to TRAIL-R1 (TR1.02).](http://images.novusbio.com/fullsize/TRAILR1-TNFRSF10A-Antibody-TR1-02-Immunohistochemistry-Paraffin-NBP2-80069-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: TRAIL R1/TNFRSF10A Antibody [NBP2-56818] - Staining of human cell line A-431 shows localization to nucleoplasm.](http://images.novusbio.com/fullsize/TRAIL-R1-TNFRSF10A-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-56818-img0001.jpg "Immunocytochemistry/Immunofluorescence: TRAIL R1/TNFRSF10A Antibody [NBP2-56818] - Staining of human cell line A-431 shows localization to nucleoplasm.")